Targeting the PRMT5-CBX8 axis overcomes dual barriers of CD8⁺ T cell exclusion and tumor stemness for sensitizing TNBC to anti-PD-1 therapy.
Cong-Cong Chen
Yu-Heng Zhang
Chang Liu
Run-Kai Zhao
Kai-Ming Liu
Zhi-Qin Guo
Yin-Yin Yang
Cong Wang
Jiaxin Tian
Yan-Fei Guo
Guo Chen
Li-Yan Jin
Xun Zhu
Dan-Yang Zhou
Guo-Qin Jiang
Medicine